Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR4)
This study is currently recruiting participants.
Verified February 2012
by Centre Val d'Aurelle - Paul Lamarque
Study NCT01333709 Information provided by Centre Val d'Aurelle - Paul Lamarque
First Received on April 8, 2011. Last Updated on February 9, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Locally Advanced Malignant Neoplasm
Rectal Carcinoma
Additional conditions recognized in this trial
Carcinoma
Neoplasms
Rectal Neoplasms
More general conditions related to this trial
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Rectal Diseases
Interventions listed in this trial
Radiochemotherapy Cap 50
Radiochemotherapy Cap 60
Additional drug interventions recognized in this trial
Camptothecin
Capecitabine
Fluorouracil
Irinotecan
Leucovorin
Oxaliplatin
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Topoisomerase I Inhibitors
Topoisomerase Inhibitors
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Centre Val d'Aurelle - Paul Lamarque
Back to top of Main Content